Current Epidemiological Approaches to the Metabolic-Cognitive Syndrome
The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
In the last decade, cumulative epidemiological evidence suggested that vascular- and metabolic-based risk factors may be important in the development of mild cognitive impairment and dementia. Epidemiological and basic research have also proposed a model of cognitive impairment linked to metabolic syndrome (MetS) and metabolic disorders, suggesting for research purposes a "metabolic-cognitive syndrome" (MCS) in patients with MetS plus cognitive impairment of degenerative or vascular origin. In particular, MetS has been associated with the risk of age-related cognitive decline and vascular dementia, but contrasting findings also existed on the possible role of MetS in overall dementia and Alzheimer's disease. Among metabolic determinants of cognitive impairment, a better approach to the understanding of mechanisms could be to hypothesize a continuum leading to various degrees of late-life cognitive disorders in older subjects with metabolic-based risk factors. The MCS model could help us to explain the complex relationship between metabolic disorders and cognitive disturbances and the boundaries between normal and pathological conditions, with a better understanding of clinical and neuropathological features of these metabolic-based cognitive disorders. Strategies toward early and effective risk factor management could be of value in reducing the risk of MCS, so delaying the onset or preventing the progression of predementia syndromes. In the near future, clinical trials could be undertaken to determine if addressing MetS and metabolic-based risk factors, including inflammation, through lifestyle modification holds out the possibility of slowing down or ameliorating the cognitive aging process itself.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Treatment of hypertension in patients 80 years of age or older
Beckett, N. S., Peters, R., Fletcher, A. E., Staessen, J. A., Liu, L., Dumitrascu, D., Stoyanovsky, V., Antikainen, R. L., Nikitin, Y., Anderson, C., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801369 · Cited by 3,092
Risk of dementia in diabetes mellitus: a systematic review
Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C., & Scheltens, P. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70284-2 · Cited by 2,187 · cited 1×
“est old [128, 129].”
Diabetes mellitus and the risk of dementia: The Rotterdam Study
Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175
Metabolic Syndrome and Risk of Incident Cardiovascular Events and Death
Gami, A. S., Witt, B. J., Howard, D. E., Erwin, P. J., Gami, L. A., Somers, V. K., & Montori, V. M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.09.032 · Cited by 1,888
Revising the definition of Alzheimer's disease: a new lexicon
Dubois, B., Feldman, H. H., Jacova, C., Cummings, J. L., DeKosky, S. T., Barberger-Gateau, P., Delacourte, A., Frisoni, G., Fox, N. C., Galasko, D., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70223-4 · Cited by 1,869 · cited 2×
“However, the recent introduction of new diagnostic criteria of AD based on specific cognitive patterns and reliable biomarkers [15] may open a new paradigm of therapeutic intervention based on the distinction of two preclinical states of AD in which individuals are free of cognitive symptoms [16].”
BackgroundComment on the provisional report from the WHO consultation
(1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00059.x · Cited by 1,820 · cited 23×
“When all components were combined together in one model, hyperglycemia was significantly associated with all cognitive measures van den Berg et al., 2008 [212] The Hoorn Study The Nethelands Cross-sectional, population-based From 2,484 participants aged 50–75 years, 64 patients with T2DM, 83 patients with MetS and 100…”
BackgroundMethodInfluential15-year longitudinal study of blood pressure and dementia
Skoog, I., Nilsson, L., Persson, G., Lernfelt, B., Landahl, S., Palmertz, B., Andreasson, L.-A., Odén, A., & Svanborg, A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90608-x · Cited by 1,726 · cited 1×
“…risk of “intermediate” cognitive function (a score between 82 and 92 on the CASI) and a 9% increased risk of poor cognition (a CASI score of 82) Skoog et al., 1996 [86] The Longitudinal Population Study of 70-year-olds Sweden Longitudinal, population-based (15 years) 382 participants aged…”
BackgroundKivipelto, M., Helkala, E.-L., Laakso, M. P., Hänninen, T., Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J., & Nissinen, A. (2001) · BMJ · doi:10.1136/bmj.322.7300.1447 · Cited by 1,618 · cited 1×
“Vascularand metabolic-based risk factors such as diabetes, obesity, hypertension, and hypercholesterolemia are well established as risk factors in the development of dementia [54, 55] and MCI [56–61].”
BackgroundForette, F., Seux, M.-L., Staessen, J. A., Thijs, L., Birkenhäger, W. H., Babarskiene, M.-R., Babeanu, S., Bossini, A., Gil-Extremera, B., Girerd, X., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03086-4 · Cited by 1,441 · cited 4×
“The suggested evidence was mixed with only one, the Systolic Hypertension in Europe (Syst-Eur) trial, showing a clear positive effect of treatment upon incident dementia [97, 98], while the Perindopril Protection against Recurrent Stroke Study (PROGRESS) did find some benefit associated with active treatment, but only…”
ResultInfluentialObesity and Vascular Risk Factors at Midlife and the Risk of Dementia and Alzheimer Disease
Kivipelto, M., Ngandu, T., Fratiglioni, L., Viitanen, M., Kåreholt, I., Winblad, B., Helkala, E.-L., Tuomilehto, J., Soininen, H., & Nissinen, A. (2005) · Archives of Neurology · doi:10.1001/archneur.62.10.1556 · Cited by 1,291 · cited 3×
“higher dementia risk [161–166] (Table 1).”
BackgroundDiabetes mellitus and risk of Alzheimer disease and decline in cognitive function
Arvanitakis, Z., Wilson, R. S., Bienias, J. L., Evans, D. A., & Bennett, D. A. (2004) · Archives of Neurology · doi:10.1001/archneur.61.5.661 · Cited by 1,258 · cited 1×
“T2DM has been also found consistently to be related to VaD, while its relation to AD is less clear [107, 139–146] (Table 1), and this risk occurs regardless of the age at onset of diabetes mellitus [76].”
BackgroundMidlife cardiovascular risk factors and risk of dementia in late life
Whitmer, R. A., Sidney, S., Selby, J., Johnston, S. C., & Yaffe, K. (2005) · Neurology · doi:10.1212/01.wnl.0000149519.47454.f2 · Cited by 1,238 · cited 4×
“Clustering of vascular risk factors increases the risk in an additive manner Whitmer et al., 2005 [162] The Kaiser Permanente Medical Care Programme USA Longitudinal, population-based (27 years) 10,276 subjects, mean age: 74.5 years Incident diagnosis of dementia A high BMI had a significant higher…”
BackgroundResultInfluentialAlzheimer’s disease: Clinical trials and drug development
Mangialasche, F., Solomon, A., Winblad, B., Mecocci, P., & Kivipelto, M. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70119-8 · Cited by 1,217 · cited 1×
“In the last decade, advances in understanding the neurobiology of AD and dementia have translated into an increase in clinical trials assessing various potential AD treatments [11–14].”
Type 2 Diabetes, APOE Gene, and the Risk for Dementia and Related Pathologies
Peila, R., Rodriguez, B. L., & Launer, L. J. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1256 · Cited by 1,207
The age-dependent relation of blood pressure to cognitive function and dementia
Qiu, C., Winblad, B., & Fratiglioni, L. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70141-1 · Cited by 1,138
Milanski, M., Degasperi, G., Coope, A., Morari, J., Denis, R., Cintra, D. E., Tsukumo, D. M. L., Anhe, G., Amaral, M. E., Takahashi, H. K., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.2760-08.2009 · Cited by 1,125
Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study
Whitmer, R. A., Gunderson, E. P., Barrett-Connor, E., Quesenberry, C. P., & Yaffe, K. (2005) · BMJ · doi:10.1136/bmj.38446.466238.e0 · Cited by 1,090
American College of Endocrinology Position Statement on the Insulin Resistance Syndrome
Einhorn, D. (2003) · Endocrine Practice · doi:10.4158/ep.9.s2.5 · Cited by 1,066 · cited 1×
“In 2003, also the American Association of Clinical Endocrinologists (AACE) modified NCEP-ATP-III criteria to refocus on insulin resistance as the primary cause of metabolic risk factors [51].”
BackgroundCognitive decline and dementia in diabetes—systematic overview of prospective observational studies
Cukierman, T., Gerstein, H. C., & Williamson, J. D. (2005) · Diabetologia · doi:10.1007/s00125-005-0023-4 · Cited by 1,049 · cited 1×
“[127], with some notable exceptions in the old-”
BackgroundThe metabolic syndrome, inflammation, and risk of cognitive decline
Yaffe, K. (2004) · JAMA · doi:10.1001/jama.292.18.2237 · Cited by 1,025 · cited 6×
“/E pidem iology ofthe M etabolic-C ognitive Syndrom e Table 1 (Continued) MetS components Reference Setting and study design Subjects Assessment of cognition or diagnosis of dementia Principal findings Luchsinger et al., 2001 [131] The Washington Heights-Inwood Columbia Aging Project USA Longitudinal, population-based…”
BackgroundInfluentialMidlife blood pressure and dementia: the Honolulu–Asia aging study☆
Launer, L. J., Ross, G. W., Petrovitch, H., Masaki, K., Foley, D., White, L. R., & Havlik, R. J. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00096-8 · Cited by 1,008
(2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.9.1069 · Cited by 988
Yoshitake, T., Kiyohara, Y., Kato, I., Ohmura, T., Iwamoto, H., Nakayama, K., Ohmori, S., Nomiyama, K., Kawano, H., Ueda, K., et al. (1995) · Neurology · doi:10.1212/wnl.45.6.1161 · Cited by 829
An 18-Year Follow-up of Overweight and Risk of Alzheimer Disease
Gustafson, D., Rothenberg, E., Blennow, K., Steen, B., & Skoog, I. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.13.1524 · Cited by 811
Central obesity and increased risk of dementia more than three decades later
Whitmer, R. A., Gustafson, D. R., Barrett-Connor, E., Haan, M. N., Gunderson, E. P., & Yaffe, K. (2008) · Neurology · doi:10.1212/01.wnl.0000306313.89165.ef · Cited by 803 · cited 1×
“…Table 1 (Continued) MetS components Reference Setting and study design Subjects Assessment of cognition or diagnosis of dementia Principal findings Whitmer et al., 2008 [163] The Kaiser Permanente Medical Care Programme USA Longitudinal, population-based (36 years) 6,583 subjects, 73 to 87 years…”
BackgroundAggregation of vascular risk factors and risk of incident Alzheimer disease
Luchsinger, J. A., Reitz, C., Honig, L. S., Tang, M. X., Shea, S., & Mayeux, R. (2005) · Neurology · doi:10.1212/01.wnl.0000172914.08967.dc · Cited by 790
Peters, R., Beckett, N., Forette, F., Tuomilehto, J., Clarke, R., Ritchie, C., Waldman, A., Walton, I., Poulter, R., Ma, S., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70143-1 · Cited by 770
The Effects of Type 1 Diabetes on Cognitive Performance
Brands, A. M. A., Biessels, G. J., de Haan, E. H. F., Kappelle, L. J., & Kessels, R. P. C. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.726 · Cited by 738 · cited 1×
“A review of 33 longitudinal studies found that in patients with type 1 diabetes mellitus that cognitive dysfunction was characterized by a slowing of mental speed and diminished mental flexibility, whereas learning and memory were spared [112].”
BackgroundMeta-analysis of Alzheimer’s disease risk with obesity, diabetes, and related disorders
Profenno, L. A., Porsteinsson, A. P., & Faraone, S. V. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.02.013 · Cited by 718
The Preclinical Phase of Alzheimer Disease: A 22-Year Prospective Study of the Framingham Cohort
Elias, M. F., Beiser, A., Wolf, P. A., Au, R., White, R. F., & D'Agostino, R. B. (2000) · Archives of Neurology · doi:10.1001/archneur.57.6.808 · Cited by 716 · cited 1×
“Although dementia is for the most part a disease of older people, epidemiological data suggest that the pathological processes leading to the disease start operating many years before the clinical onset [80, 81], with age as an important modulator of the association between vascular risk factors and dementia [82].”
BackgroundRisk of Dementia among Persons with Diabetes Mellitus: A Population-based Cohort Study
Leibson, C. L., Rocca, W. A., Hanson, V. A., Cha, R., Kokmen, E., O'Brien, P. C., & Palumbo, P. J. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009106 · Cited by 700 · cited 24×
“When all components were combined together in one model, hyperglycemia was significantly associated with all cognitive measures van den Berg et al., 2008 [212] The Hoorn Study The Nethelands Cross-sectional, population-based From 2,484 participants aged 50–75 years, 64 patients with T2DM, 83 patients with MetS and 100…”
BackgroundInfluentialHyperinsulinemia and risk of Alzheimer disease
Luchsinger, J. A., Tang, M.-X., Shea, S., & Mayeux, R. (2004) · Neurology · doi:10.1212/01.wnl.0000140292.04932.87 · Cited by 683
Diabetes Mellitus and Risk of Alzheimer's Disease and Dementia with Stroke in a Multiethnic Cohort
Luchsinger, J. A. (2001) · American Journal of Epidemiology · doi:10.1093/aje/154.7.635 · Cited by 682
Hypertension Is Related to Cognitive Impairment: A 20-Year Follow-up of 999 Men
Kilander, L., Nyman, H., Boberg, M., Hansson, L., & Lithell, H. (1998) · Hypertension · doi:10.1161/01.hyp.31.3.780 · Cited by 630
Relation of diabetes to mild cognitive impairment
Luchsinger, J. A., Reitz, C., Patel, B., Tang, M.-X., Manly, J. J., & Mayeux, R. (2007) · Archives of Neurology · doi:10.1001/archneur.64.4.570 · Cited by 592
Beydoun, M. A., Beydoun, H. A., & Wang, Y. (2008) · Obesity Reviews · doi:10.1111/j.1467-789x.2008.00473.x · Cited by 563 · cited 22×
“Processing speed tests was negatively associated with duration of disease Cukierman-Yaffe et al., 2009 [120] Memory in Diabetes (MIND) substudy of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial USA/Canada Randomizrd clinical trial 2,977 trial participants with established T2DM (mean age: 62.5 yea…”
BackgroundInfluentialThe Role of Metabolic Disorders in Alzheimer Disease and Vascular Dementia: Two Roads Converged
Craft, S. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.27 · Cited by 547 · cited 3×
“Furthermore, epidemiological evidence suggested that obesity, dyslipidemia, and hypertension in midlife are associated with late-life cognitive disorders, and dementia onset may be associated with counter-regulatory factors that alter the presentation of the risk-initiating metabolic condition [106].”
BackgroundVascular risk factors, incidence of MCI, and rates of progression to dementia
Solfrizzi, V., Panza, F., Colacicco, A. M., D’Introno, A., Capurso, C., Torres, F., Grigoletto, F., Maggi, S., Del Parigi, A., Reiman, E. M., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000144281.38555.e3 · Cited by 530
Self-citationIs Diabetes Associated With Cognitive Impairment and Cognitive Decline Among Older Women?
Gregg, E. W. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.2.174 · Cited by 521
Diabetes, impaired fasting glucose, and development of cognitive impairment in older women
Yaffe, K., Blackwell, T., Kanaya, A. M., Davidowitz, N., Barrett-Connor, E., & Krueger, K. (2004) · Neurology · doi:10.1212/01.wnl.0000134666.64593.ba · Cited by 520
Stewart, R., Masaki, K., Xue, Q.-L., Peila, R., Petrovitch, H., White, L. R., & Launer, L. J. (2005) · Archives of Neurology · doi:10.1001/archneur.62.1.55 · Cited by 478
Lopez, O. L., Jagust, W. J., Dulberg, C., Becker, J. T., DeKosky, S. T., Fitzpatrick, A., Breitner, J., Lyketsos, C., Jones, B., Kawas, C., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.10.1394 · Cited by 477
Kalmijn, S., Foley, D., White, L., Burchfiel, C. M., Curb, J. D., Petrovitch, H., Ross, G. W., Havlik, R. J., & Launer, L. J. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.10.2255 · Cited by 417 · cited 7×
“Considering overall dementia, there is only one longitudinal population-based study suggesting an association between MetS and incident dementia [209], while the other four longitudinal populationbased studies that considered this particular outcome did not find an increased risk of developing overall dementia linked…”
BackgroundResultInfluentialRelation of Plasma Lipids to Alzheimer Disease and Vascular Dementia
Reitz, C., Tang, M.-X., Luchsinger, J., & Mayeux, R. (2004) · Archives of Neurology · doi:10.1001/archneur.61.5.705 · Cited by 397 · cited 1×
“Hyperlipidemia has also been found, although not in all studies [190], to increase the risk of dementia [83].”
ResultObesity, diabetes and cognitive deficit: The Framingham Heart Study
Elias, M. F., Elias, P. K., Sullivan, L. M., Wolf, P. A., & D’Agostino, R. B. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.08.019 · Cited by 395 · cited 1×
“Some studies suggest that the longer the duration of diabetes mellitus, the poorer the cognitive function [118–120] (Table 1).”
BackgroundKloppenborg, R. P., van den Berg, E., Kappelle, L. J., & Biessels, G. J. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.02.049 · Cited by 368
Risk Factors for Vascular Dementia and Alzheimer Disease
Gorelick, P. B. (2004) · Stroke · doi:10.1161/01.str.0000143318.70292.47 · Cited by 365 · cited 3×
“There are many notable observational epidemiological studies that have helped clarify the role of vascular risk factors in MCI, dementia, and AD [54].”
BackgroundHypertension and the Risk of Mild Cognitive Impairment
Reitz, C., Tang, M.-X., Manly, J., Mayeux, R., & Luchsinger, J. A. (2007) · Archives of Neurology · doi:10.1001/archneur.64.12.1734 · Cited by 360 · cited 3×
“…aged 60–76 years Diagnosis of MCI This study also found that hypertension was related to a higher risk of MCI, without distinction of MCI subtype Reitz et al., 2007 [74] The Washington Heights-Inwood Columbia Aging Project USA Longitudinal, population-based (4.7 years) 918 participants (aged…”
BackgroundInfluentialAllen, K. V., Frier, B. M., & Strachan, M. W. J. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.054 · Cited by 319
McGuinness, B., Todd, S., Passmore, P., & Bullock, R. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004034.pub3 · Cited by 315 · cited 8×
“Recent evidence from populationbased studies and case series suggests that vascular risk factors and CVD may contribute to the heterogeneity of MCI [26, 60–65].”
ResultInfluentialMacKnight, C., Rockwood, K., Awalt, E., & McDowell, I. (2002) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000064928 · Cited by 313 · cited 3×
“…CIND), although the effect on CIND without stroke was not evident after adjusting for demographic variables and the presence of the APOE ε4 allele MacKnight et al., 2002 [132] The Canadian Study of Health and Aging Canada Longitudinal, population-based (5 years) 5,574 older subjects, aged 65…”
BackgroundTervo, S., Kivipelto, M., Hänninen, T., Vanhanen, M., Hallikainen, M., Mannermaa, A., & Soininen, H. (2004) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000076356 · Cited by 298 · cited 3×
“…Table 1 (Continued) MetS components Reference Setting and study design Subjects Assessment of cognition or diagnosis of dementia Principal findings Tervo et al., 2004 [73] The Kuopio Study Finland Longitudinal, population-based (3 years) 806 older subjects, aged 60–76 years Diagnosis of MCI This…”
BackgroundFontbonne, A., Berr, C., Ducimetière, P., & Alpérovitch, A. (2001) · Diabetes Care · doi:10.2337/diacare.24.2.366 · Cited by 297
25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services
Buell, J. S., Dawson-Hughes, B., Scott, T. M., Weiner, D. E., Dallal, G. E., Qui, W. Q., Bergethon, P., Rosenberg, I. H., Folstein, M. F., Patz, S., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181beecb7 · Cited by 288
Kanaya, A. M., Barrett-Connor, E., Gildengorin, G., & Yaffe, K. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.12.1327 · Cited by 255 · cited 2×
“…low cognitive score) Diabetic as well as pre-diabetic women have impaired cognitive performance and greater risk of developing cognitive impairment Kanaya et al., 2004 [114] The Rancho Bernardo Study USA Longitudinal, population-based (4 years) 999 white men and women aged 42 to 89 years Three…”
BackgroundResultAdiposity indices and dementia
Gustafson, D. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70526-9 · Cited by 237
Type 2 Diabetes and Cognitive Function in Community-Dwelling Elderly Women
Grodstein, F., Chen, J., Wilson, R. S., & Manson, J. E. (2001) · Diabetes Care · doi:10.2337/diacare.24.6.1060 · Cited by 223
The Metabolic Syndrome and Development of Cognitive Impairment Among Older Women
Yaffe, K., Weston, A. L., Blackwell, T., & Krueger, K. A. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.566 · Cited by 220 · cited 5×
“In fact, the Multiple Outcomes of Raloxifene Evaluation (MORE) dementia ancillary study showed an association between MetS and an increased risk of developing cognitive impairment (defined as a composite outcome: clinically adjudicated dementia or MCI or cognitive impairment not clinically adjudicated), during a 4-yea…”
BackgroundInfluentialBody mass index and incidence of dementia: The PAQUID study
Nourhashémi, F., Deschamps, V., Larrieu, S., Letenneur, L., Dartigues, J.-F., & Barberger-Gateau, P. (2003) · Neurology · doi:10.1212/01.wnl.0000038910.46217.aa · Cited by 193
Cardiovascular Risk Factors and Incident Alzheimer Disease: A Systematic Review of the Literature
Purnell, C., Gao, S., Callahan, C. M., & Hendrie, H. C. (2009) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318187541c · Cited by 189 · cited 3×
“MCI [25–28], a few studies have looked at the com-”
BackgroundMetabolic syndrome and dementia risk in a multiethnic elderly cohort
Muller, M., Tang, M.-X., Schupf, N., Manly, J. J., Mayeux, R., & Luchsinger, J. A. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000105927 · Cited by 175 · cited 5×
“, 2007 [235] The Washington Heights-Inwood Columbia Aging Project (WHICAP) Raffaitin et al.”
BackgroundResultInfluentialThe risk of dementia with increased body mass index
Gorospe, E. C., & Dave, J. K. (2006) · Age and Ageing · doi:10.1093/ageing/afl123 · Cited by 162 · cited 2×
“baseline [160].”
Cognitive function and hypertension
Birns, J., & Kalra, L. (2009) · Journal of Human Hypertension · doi:10.1038/jhh.2008.80 · Cited by 157
Saczynski, J. S., Jonsdottir, M. K., Garcia, M. E., Jonsson, P. V., Peila, R., Eiriksdottir, G., Olafsdottir, E., Harris, T. B., Gudnason, V., & Launer, L. J. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn228 · Cited by 142
Morley, J. E., & Banks, W. A. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091576 · Cited by 108 · cited 1×
“[174–176], and that both elevated plasma triglycerides”
Mid‐life adiposity factors relate to blood–brain barrier integrity in late life
Gustafson, D. R., Karlsson, C., Skoog, I., Rosengren, L., Lissner, L., & Blennow, K. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01869.x · Cited by 107 · cited 1×
“Obesity and/or high BMI are emerging risk markers of interest because of its metabolic consequences and recent reports of associations with dementia [79, 150] and poorer cognitive function in populationbased investigations [151], and because obesity affects 25–30% of adults in industrialized countries [152] (Table 1).”
BackgroundBirns, J., Morris, R., Donaldson, N., & Kalra, L. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000244934.81180.16 · Cited by 96 · cited 1×
“A systematic review found that a relatively small reduction in BP (<5/3 mm Hg) was associated with improvements in Mini Mental State Examination (MMSE) scores and performance on memory tasks [102].”
Background
Cited by
The role of autophagy in neurodegenerative disease
Nixon, R. A. (2013) · Nature Medicine · doi:10.1038/nm.3232 · Cited by 2,059
Stroke injury, cognitive impairment and vascular dementia
Kalaria, R. N., Akinyemi, R., & Ihara, M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.01.015 · Cited by 647
Dichgans, M., & Leys, D. (2017) · Circulation Research · doi:10.1161/circresaha.116.308426 · Cited by 581
Panza, F., Lozupone, M., Solfrizzi, V., Sardone, R., Dibello, V., Di Lena, L., D’Urso, F., Stallone, R., Petruzzi, M., Giannelli, G., et al. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170963 · Cited by 337
Self-citationNutrition for the ageing brain: Towards evidence for an optimal diet
Vauzour, D., Camprubi-Robles, M., Miquel-Kergoat, S., Andres-Lacueva, C., Bánáti, D., Barberger-Gateau, P., Bowman, G. L., Caberlotto, L., Clarke, R., Hogervorst, E., et al. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.010 · Cited by 241
“…may be important in the development of ge-related cognitive decline, mild cognitive impairment, vascuar dementia, and AD (Frisardi et al., 2010; Panza et al., 2012b). lthough some understanding exists regarding the role of glucose nd insulin within the central nervous system (CNS), the…”
Metadata
- Authors
- Panza, F., Solfrizzi, V., Logroscino, G., Maggi, S., Santamato, A., Seripa, D., & Pilotto, A.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2012-06-08
- Volume
- 30
- Issue
- s2
- Pages
- S31-S75
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W191659063
- Cited by
- 52
- References
- 67
- FWCI
- 4.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.